-transparent.png){kind=logo}
The pharmacokinetics of theophylline were examined in eight low-birth-weight infants (gestation: 26-32 weeks: birth-weight: 887-1,480 gm), who received the drug for treatment of primary apnea. The drug was assayed by high pressure liquid chromatography. The final dosage was 1 to 3 mg/kg/6 hour at 25 to 37 days of age. At the time, theophylline had a prolonged half-life ranging from 13 to 29 hours, a relatively large volume of distribution of 0.65 to 2.86 1/kg, and a small body clearance of 23 to 68 ml/hr/kg. The extremely slow and variable elimination of theophylline must be considered in treatment of apneic infants. The initial dosage regimen suggested is a loading dose of 6 mg/kg and a maintenance dose of 2 mg/kg/ 12 hours, with adjustments made based on monitoring of the serum concentration and on an increased biotransformation capability as maturation occurs.
G Giacoia, and
W J Jusko, and
J Menke, and
J R Koup
December 1981,
Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde,
G Giacoia, and
W J Jusko, and
J Menke, and
J R Koup
June 2013,
Therapeutic drug monitoring,
G Giacoia, and
W J Jusko, and
J Menke, and
J R Koup
December 2005,
Journal of clinical pharmacy and therapeutics,
G Giacoia, and
W J Jusko, and
J Menke, and
J R Koup
January 1985,
Archives francaises de pediatrie,
G Giacoia, and
W J Jusko, and
J Menke, and
J R Koup
August 1978,
Monatsschrift fur Kinderheilkunde,
G Giacoia, and
W J Jusko, and
J Menke, and
J R Koup
January 1979,
Minerva pediatrica,
G Giacoia, and
W J Jusko, and
J Menke, and
J R Koup
March 1996,
British journal of clinical pharmacology,
G Giacoia, and
W J Jusko, and
J Menke, and
J R Koup
March 1981,
Pediatrie,
G Giacoia, and
W J Jusko, and
J Menke, and
J R Koup
April 2008,
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
G Giacoia, and
W J Jusko, and
J Menke, and
J R Koup
January 1978,
Archives francaises de pediatrie,
